I went back through your very informative posts until the 30/4. At that time you mentioned 3 additional indications for phase II trials that Rohan had mentioned.
Acute ischaemic optic atrophy, Leber and Glaucoma. It seems like the first has dropped off the list. Maybe it’s hard to do trials on an acute event? Any thoughts? Do you have any information regarding this indication similar to Lebers and Glaucoma or if it’s not mentioned is it likely it’s not on the list of potential trials any more.
Also apologies to counterfiat. I managed to get the ****** site working and listened to the interview. I went back and reread your post and I see you were looking for twelve trials not 8.
PYC Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)